Publications (16 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Vitalievna SE (2021) Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques. Scientific Research Institute of therapy and preventive medicine. Thesis.
* Stryukova EV (2021) Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates. Federal Research Center Institue of Cytology and Genetics of the Siberian Branch Russian Academy of Sciences. Dissertation.
* Cassel A et al. (2021) Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization. Res Pract Thromb Haemost. 5(4):e12407.
* Andreeva TA et al. (2020) STUDY OF IMMUNOGENICITY OF THE RUSSIAN RECOMBINANT ACTIVATED COAGING FACTOR VII IN PATIENTS WITH HEMOPHILIA A COMPLICATED BY THE DEVELOPMENT OF INHIBITORS. Pediatriya. 99(2):206-215
* Ragino YI et al. (2019) Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. BMC Res Notes. 12(1):336.
* Madkhali Y et al. (2019) The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells. TH Open. 3(2): e132-e145
* Featherby S et al. (2019) Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity. Thromb Haemost. 119(9):1419-1432.
* Gennadievna LY (2018) Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart. Tomsk National Research Medical Center of the Russian Academy of Sciences
* Takikawa Y et al. (2014) Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease. Hepatol Res. 44(1):92-101
* Jiang M et al. (2011) A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis. 22(4):264-270
* Criado-Garcia J et al. (2011) R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study. Lipids in Health and Disease 10:50
* Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2
* Andersson E et al. (2010) Tissue factor in predicted severe acute pancreatitis. World J Gastroenterol 16(48): 6128-6134
* Giovagnoli A et al. (2009) Cell culture processes. USPTO Patent Applicaton #: US20090176269 A1
* He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51
* Meyer TV (2002) Cellular effects of tissue factor binding proteins. University of South Florida. ProQuest Dissertations Publishing, 3052656.
